Related Experiment Videos
Human alpha 1-microglobulin levels in neurological disorders.
European Neurology
|January 1, 1983
Summary
Alpha 1-microglobulin (alpha 1-m) levels in cerebrospinal fluid (CSF) were elevated in neurological disorders like viral meningitis and cerebral infarct. Increased CSF alpha 1-m suggests blood-brain barrier damage, though local production isn't excluded.
Area of Science:
- Neurology
- Biochemistry
- Immunology
Background:
- Alpha 1-microglobulin (alpha 1-m) is a protein found in serum and other body fluids.
- Its role and concentration in cerebrospinal fluid (CSF) in neurological conditions require further investigation.
Purpose of the Study:
- To measure alpha 1-microglobulin (alpha 1-m) concentrations in serum and CSF of patients with neurological disorders.
- To investigate the relationship between alpha 1-m levels and specific neurological conditions.
Main Methods:
- Serum alpha 1-m measured using single radial immunodiffusion.
- CSF alpha 1-m quantified via radioimmunoassay with a solid antibody system.
- 121 patients with various neurological disorders and healthy controls were analyzed.
Main Results:
- Serum alpha 1-m levels showed no significant difference between patients and controls.
- CSF alpha 1-m levels were significantly elevated in viral meningitis and cerebral infarct.
- Elevated CSF alpha 1-m was also observed in brain tumors, bacterial meningitis, cerebral hemorrhage, cervical spondylosis, and leukemia.
- A positive correlation was found between CSF alpha 1-m and albumin levels.
Conclusions:
- Increased CSF alpha 1-m in neurological disorders is primarily attributed to enhanced blood-brain barrier permeability.
- Serum alpha 1-m passage into the CSF is likely increased due to damaged blood-brain barrier.
- The possibility of local alpha 1-m production within the central nervous system cannot be excluded.